159 related articles for article (PubMed ID: 11754813)
21. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
Mihelic M; Dobersek A; Guncar G; Turk D
J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
[TBL] [Abstract][Full Text] [Related]
22. Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S.
Gresser O; Weber E; Hellwig A; Riese S; Régnier-Vigouroux A
Eur J Immunol; 2001 Jun; 31(6):1813-24. PubMed ID: 11433378
[TBL] [Abstract][Full Text] [Related]
23. The p41 isoform of invariant chain is a chaperone for cathepsin L.
Lennon-Duménil AM; Roberts RA; Valentijn K; Driessen C; Overkleeft HS; Erickson A; Peters PJ; Bikoff E; Ploegh HL; Wolf Bryant P
EMBO J; 2001 Aug; 20(15):4055-64. PubMed ID: 11483509
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of major histocompatibility complex class II compartments in cortical thymic epithelial cells.
Arudchelvan Y; Nishimura Y; Tokuda N; Sawada T; Ueyama Y; Fukumoto T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):798-806. PubMed ID: 12923890
[TBL] [Abstract][Full Text] [Related]
25. Comparative contribution of CD1 on the development of CD4+ and CD8+ T cell compartments.
Wang B; Chun T; Wang CR
J Immunol; 2000 Jan; 164(2):739-45. PubMed ID: 10623818
[TBL] [Abstract][Full Text] [Related]
26. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.
Wiendl H; Lautwein A; Mitsdörffer M; Krause S; Erfurth S; Wienhold W; Morgalla M; Weber E; Overkleeft HS; Lochmüller H; Melms A; Tolosa E; Driessen C
J Neuroimmunol; 2003 May; 138(1-2):132-43. PubMed ID: 12742663
[TBL] [Abstract][Full Text] [Related]
27. A population of CD62Llow Nk1.1- CD4+ T cells that resembles NK1.1+ CD4+ T cells.
Chen H; Paul WE
Eur J Immunol; 1998 Oct; 28(10):3172-82. PubMed ID: 9808186
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation.
Lankar D; Vincent-Schneider H; Briken V; Yokozeki T; Raposo G; Bonnerot C
J Exp Med; 2002 Feb; 195(4):461-72. PubMed ID: 11854359
[TBL] [Abstract][Full Text] [Related]
29. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
Fineschi B; Sakaguchi K; Appella E; Miller J
J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
[TBL] [Abstract][Full Text] [Related]
30. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
[TBL] [Abstract][Full Text] [Related]
31. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1.
Chen H; Paul WE
J Immunol; 1997 Sep; 159(5):2240-9. PubMed ID: 9278312
[TBL] [Abstract][Full Text] [Related]
32. IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells.
Hameg A; Gouarin C; Gombert JM; Hong S; Van Kaer L; Bach JF; Herbelin A
J Immunol; 1999 Jun; 162(12):7067-74. PubMed ID: 10358149
[TBL] [Abstract][Full Text] [Related]
33. Cathepsin S activity regulates antigen presentation and immunity.
Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin S, but not cathepsin L, participates in the MHC class II-associated invariant chain processing in large yellow croaker (Larimichthys crocea).
Li Q; Ao J; Mu Y; Yang Z; Li T; Zhang X; Chen X
Fish Shellfish Immunol; 2015 Dec; 47(2):743-50. PubMed ID: 26475363
[TBL] [Abstract][Full Text] [Related]
36. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.
Nakagawa TY; Rudensky AY
Immunol Rev; 1999 Dec; 172():121-9. PubMed ID: 10631942
[TBL] [Abstract][Full Text] [Related]
37. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.
Maubach G; Lim MC; Kumar S; Zhuo L
Biochim Biophys Acta; 2007 Feb; 1773(2):219-31. PubMed ID: 17178165
[TBL] [Abstract][Full Text] [Related]
38. The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments.
Schneppenheim J; Loock AC; Hüttl S; Schweizer M; Lüllmann-Rauch R; Oberg HH; Arnold P; Lehmann CHK; Dudziak D; Kabelitz D; Lucius R; Lennon-Duménil AM; Saftig P; Schröder B
J Immunol; 2017 Jul; 199(1):172-185. PubMed ID: 28550201
[TBL] [Abstract][Full Text] [Related]
39. Cathepsins and compartmentalization in antigen presentation.
Riese RJ; Chapman HA
Curr Opin Immunol; 2000 Feb; 12(1):107-13. PubMed ID: 10679409
[TBL] [Abstract][Full Text] [Related]
40. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
Burdin N; Brossay L; Kronenberg M
Eur J Immunol; 1999 Jun; 29(6):2014-25. PubMed ID: 10382765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]